The Cannabis Sector Is Ready for an Implosion: 1,500% Acquisition Premiums Make No Sense

Why Aphria Inc. (TSX:APH) agreeing to buy Broken Coast Cannabis Inc. for $230 million is a valuation exercise which needs to be completed in some alternative dimension where fundamentals do not matter.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

With most Canadian cannabis producers now swimming in a sea of “funny money,” some funny math has taken over in the acquisition metrics used by firms such as Aphria Inc. (TSX:APH) in agreeing to buy Broken Coast Cannabis Inc. for $230 million on earlier this week, as covered by fellow Fool contributor Joseph Solitro.

While Mr. Solitro appears to be very bullish on the long-term prospects of Aphria following the announcement of this acquisition as well as a couple of other recent strategic moves made by Aphria, looking at the multiple paid for Broken Coast, I’m surprised the stock didn’t tank the minute the acquisition was announced.

According to Chris Damas of BCMI Research (one of the most reputable sources on the industry and the metrics behind the cannabis sector), Aphria has valued Broken Coast’s productive capacity at more than $5,200 per square foot, while comparable production capacity has been built from scratch for approximately $333 per square foot.

In other words, Aphria just paid 15.7 times more than what it could have paid if it decided to buy land and build a production facility from scratch.

This isn’t even the most ridiculous valuation metric one can ascribe to the deal; taking into consideration how much Aphria just paid for access to Broken Coast’s loyal customers, an easy $23,000 per patient was paid to Broken Coast for the honour of selling pot to each of its customers! While other firms, such as Canopy Growth Corp., have paid more on a per-patient basis for other acquisitions (as high as $26,000 per patient), seeing these numbers makes my eyes water, as I consider how much pot must be sold to these customers over time to make up the exorbitant acquisition cost taken on the backs of Aphria equity holders.

Bottom line

The argument that Aphria is doing the right thing in issuing shares ($220 million out of the $230 million will come from new equity) to acquire firms requires some funny logic in addition to the funny math. The logic goes:

  • A first-mover advantage is the only important thing cannabis companies should be shooting for right now.
  • The amount paid for an acquisition really doesn’t matter, as the share price will continue to climb, and marijuana producers can simply issue new shares at higher prices, diluting the current shareholder base by smaller amounts over time.
  • Productive capacity is somehow worth 15 times more today than it would be in one or two years from now.

The math and the logic make no sense whatsoever. When money is free and valuations continue to go to new ridiculous levels, fundamentals mean less and less. Who knows when the sector will implode, but I can tell you, I will never step foot in this sector in 2018 and beyond, until fundamentals show some semblance of reality.

Stay Foolish, my friends.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any stocks mentioned in this article.

More on Investing

Investing

KM Throwaway Post

Read more »

Investing

Carlos Test Yoast Metadata

Read more »

Investing

KM Ad Test

This is my excerpt.

Read more »

Investing

Test post for affiliate partner mockups

Updated: 9/17/2024. This post was not sponsored. The views and opinions expressed in this review are purely those of the…

Read more »

Investing

Testing Ecap Error

Premium content from Motley Fool Stock Advisor We here at Motley Fool Stock Advisor believe investors should own at least…

Read more »

Investing

TSX Today: Testing the Ad for James

la la la dee dah.

Read more »

Lady holding remote control pointed towards a TV
Investing

2 Streaming Stocks to Buy Now and 1 to Run From

There are streaming stocks on the TSX that are worth paying attention to in 2023 and beyond.

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Stocks for Beginners

Top Recession-Resilient TSX Stocks to Buy With $3,000

It's time to increase your exposure to defensives!

Read more »